Investors have responded warmly to the FSA's announcment that it plans to monitor the financial health of firms on a case-by-case basis by reversing the slide in Royal & SunAlliance's (R&SA) share price.
Investors have responded warmly to the FSA's announcement that it plans to monitor the financial health of firms on a case-by-case basis by reversing the slide in Royal & SunAlliance's (R&SA) share price.
The FSA announced earlier today that it revealed plans to monitor the financial health of firms on a case-by-case basis.
At 16.20pm on Thursday, R&SA's share price was 61pence, up by 8.4%.
In January insurers were told they would no longer have to meet a benchmark known as the Required Minimum Margin (RMM).
The move was designed to prevent insurers from dumping shares to maintain solvency.
